Axsome Flashes A Bearish Signal On Mixed Results In Alzheimer's Agitation
Shares of Axsome Therapeutics dropped Monday on mixed test results for its Alzheimer's disease agitation treatment.
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Shares of Axsome Therapeutics dropped Monday on mixed test results for its Alzheimer's disease agitation treatment.